Probing the mechanisms underlying human diseases in making ribosomes

Biochemical Society Transactions

Volumn 44, Issue 4, 2016, Pages 1035-1044

  Farley, Katherine I ^a   Baserga, Susan J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ribosome biogenesis; Ribosomopathies; Specialized ribosomes

Indexed keywords

MESSENGER RNA; PROTEIN P53; RIBOSOME PROTEIN; RIBOSOME RNA; UBIQUITIN;

ARTICLE; DNA MODIFICATION; GENE MUTATION; HUMAN; PHENOTYPE; PHYSICAL DISEASE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN STABILITY; RIBOSOME; RNA SEQUENCE; RNA TRANSLATION; TISSUE SPECIFICITY; TRANSLATION REGULATION; BIOLOGICAL MODEL; DISEASES; GENETICS; MANDIBULOFACIAL DYSOSTOSIS; METABOLISM; MUTATION; PROTEIN SYNTHESIS;

DISEASE; HUMANS; MANDIBULOFACIAL DYSOSTOSIS; MODELS, GENETIC; MUTATION; PROTEIN BIOSYNTHESIS; RIBOSOMAL PROTEINS; RIBOSOMES; RNA, RIBOSOMAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85009740943     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20160064     Document Type: Article

References (111)

1. De Keersmaecker, K., Sulima, S.O. and Dinman, J.D. (2015) Ribosomopathies and the paradox of cellular hypo-to hyperproliferation. Blood 125, 1377-1382 CrossRef PubMed.
2. De Keersmaecker, K., Atak, Z.K., Li, N., Vicente, C., Patchett, S., Girardi, T., Gianfelici, V., Geerdens, E., Clappier, E., Porcu, M. et al. (2013) Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat. Genet. 45, 186-190 CrossRef PubMed.
3. Novetsky, A.P., Zighelboim, I., Thompson, D.M., Powell, M.A., Mutch, D.G. and Goodfellow, P.J. (2013) Frequent Mutations in the RPL22 Gene and its Clinical and Functional Implications. Gynecol. Oncol. 128, 470-474 CrossRef.
4. Wang, K., Kan, J., Yuen, S.T., Shi, S.T., Chu, K.M., Law, S., Chan, T.L., Kan, Z., Chan, A.S., Tsui, W.Y. et al. (2011) Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 43, 1219-1223 CrossRef PubMed.
5. Glader, B.E., Backer, K. and Diamond, L.K. (1983) Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N. Engl. J. Med. 309, 1486-1490 CrossRef PubMed.
6. Halperin, D.S. and Freedman, M.H. (1989) Diamond-Blackfan anemia: etiology, pathophysiology, and treatment. Am. J. Pediatr. Hematol. Oncol. 11, 380-394 PubMed.
7. Collins, T.E. (1900) Cases with symmetrical congenital notches in the outer part of each lid and defective development of the malar bones. Trans. Ophthalmol. Soc. U.K. 20, 190-192.
8. Bolze, A., Mahlaoui, N., Byun, M., Turner, B., Trede, N., Ellis, S.R., Abhyankar, A., Itan, Y., Patin, E., Brebner, S. et al. (2013) Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science 340, 976-978 CrossRef PubMed.
9. Myerson, R.M. and Koelle, W.A. (1956) Congenital absence of the spleen in an adult, report of a case associated with recurrent Waterhouse-Friderichsen syndrome. N. Engl. J. Med. 254, 1131-1132 CrossRef PubMed.
10. Betard, C., Rasquin-Weber, A., Brewer, C., Drouin, E., Clark, S., Verner, A., Darmond-Zwaig, C., Fortin, J., Mercier, J., Chagnon, P. et al. (2000) Localization of a recessive gene for North American Indian childhood cirrhosis to chromosome region 16q22-and identification of a shared haplotype. Am. J. Hum. Genet. 67, 222-228 CrossRef PubMed.
11. Heiss, N.S., Knight, S.W., Vulliamy, T.J., Klauck, S.M., Wiemann, S., Mason, P.J., Poustka, A. and Dokal, I. (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32-38 CrossRef PubMed.
12. Lafontaine, D.L., Bousquet-Antonelli, C., Henry, Y., Caizergues-Ferrer, M. and Tollervey, D. (1998) The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev. 12, 527-537 CrossRef PubMed.
13. Dokal, I. (1996) Dyskeratosis congenita: An inherited bone marrow failure syndrome. Br. J. Haematol. 92, 775-779 CrossRef PubMed.
14. Dokal, I. (2000) Dyskeratosis congenita in all its forms. Br. J. Haematol. 110, 768-779 CrossRef PubMed.
15. p53 stability by Mdm2. Nature 387, 299-303 CrossRef PubMed.
16. p53. Nature 387, 296-299 CrossRef PubMed.
17. p53. FEBS Lett. 420, 25-27 CrossRef PubMed.
18. p53 in tumor initiation and progression. Cold Spring Harb. Perspect. Med. 6, 1-15 CrossRef.
19. p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol. Cell. Biol. 21, 4246-4255 CrossRef PubMed.
20. Strezoska, Z., Pestov, D.G. and Lau, L.F. (2000) Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5. 8S RRNA processing and 60S ribosome biogenesis. Mol. Cell. Biol. 20, 5516-5528 CrossRef PubMed.
21. p53 in response to DNA damage and other stresses. EMBO J. 22, 6068-6077 CrossRef PubMed.
22. p53 activation upon ribosomal biogenesis stress. Proc. Natl. Acad. Sci. U.S.A. 109, 20467-20472 CrossRef PubMed.
23. p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes. Dev. 26, 1028-1040 CrossRef PubMed.
24. p53 activation. J. Biol. Chem. 285, 25812-25821 CrossRef PubMed.
25. Macias, E., Jin, A., Deisenroth, C., Bhat, K., Mao, H., Lindstrom, M.S. and Zhang, Y. (2010) An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 18, 231-243 CrossRef PubMed.
26. p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep. 5, 237-247 CrossRef PubMed.
27. p53 checkpoint. Cell Rep. 4, 87-98 CrossRef PubMed.
28. p53 loop. Oncotarget 7, 16217-16226.
29. p53 response and a new target for cancer therapy. Biochim. Biophys. Acta 1849, 821-829 CrossRef PubMed.
30. p53 and induces cell cycle arrest via inhibition of MDM2. Mol. Cell. Biol. 28, 4365-4376 CrossRef PubMed.
31. Sugimoto, M., Kuo, M.L., Roussel, M.F. and Sherr, C.J. (2003) Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 11, 415-424 CrossRef PubMed.
32. Itahana, K., Bhat, K.P., Jin, A., Itahana, Y., Hawke, D., Kobayashi, R. and Zhang, Y. (2003) Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12, 1151-1164 CrossRef PubMed.
33. Bertwistle, D., Sugimoto, M. and Sherr, C.J. (2004) Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24, 985-996 CrossRef PubMed.
34. p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96, 14973-14977 CrossRef PubMed.
35. p53 activation by DNA damage. Genes Dev. 15, 1067-1077 CrossRef PubMed.
36. p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J 28, 3857-3867 CrossRef PubMed.
37. p53 regulation. EMBO J. 21, 3715-3727 CrossRef PubMed.
38. Dias, S.S., Milne, D.M. and Meek, D.W. (2006) c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF. Oncogene 25, 6666-6671 CrossRef PubMed.
39. p53 nuclear export. Oncogene 22, 8870-8880 CrossRef PubMed.
40. p53 by ATM in response to DNA damage. Science 281, 1674-1677 CrossRef PubMed.
41. p53. Genes Dev 13, 152-157 CrossRef PubMed.
42. p53. Science 281, 1677-1679 CrossRef PubMed.
43. Danilova, N., Bibikova, E., Covey, T.M., Nathanson, D., Dimitrova, E., Konto, Y., Lindgren, A., Glader, B., Radu, C.G., Sakamoto, K.M. and Lin, S. (2014) The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia. Dis. Model Mech. 7, 895-905 CrossRef PubMed.
44. Altug Teber, O., Gillessen-Kaesbach, G., Fischer, S., Bohringer, S., Albrecht, B., Albert, A., Arslan-Kirchner, M., Haan, E., Hagedorn-Greiwe, M., Hammans, C., Henn, W. et al. (2004) Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur. J. Hum. Genet. 12, 879-890 CrossRef PubMed.
45. Dauwerse, J.G., Dixon, J., Seland, S., Ruivenkamp, C.A., van Haeringen, A., Hoefsloot, L.H., Peters, D.J., Boers, A.C., Daumer-Haas, C., Maiwald, R. et al. (2011) Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat. Genet. 43, 20-22 CrossRef PubMed.
46. Bowman, M., Oldridge, M., Archer, C., O'Rourke, A., McParland, J., Brekelmans, R., Seller, A. and Lester, T. (2012) Gross deletions in TCOF1 are a cause of Treacher-Collins-Franceschetti syndrome. Eur. J. Hum. Genet. 20, 769-777 CrossRef PubMed.
47. Splendore, A., Silva, E.O., Alonso, L.G., Richieri-Costa, A., Alonso, N., Rosa, A., Carakushanky, G., Cavalcanti, D.P., Brunoni, D. and Passos-Bueno, M.R. (2000) High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes. Hum. Mutat. 16, 315-322 CrossRef PubMed.
48. p53 function. Nat. Med. 14, 125-133 CrossRef PubMed.
49. Griffin, J.N., Sondalle, S.B., del Viso, F., Baserga, S.J. and Khokha, M.K. (2015) The ribosome biogenesis factor Nol11 is required for optimal rDNA transcription and craniofacial development in Xenopus. PLoS Genet. 11, e1005018 CrossRef PubMed.
50. Zhao, C., Andreeva, V., Gibert, Y., LaBonty, M., Lattanzi, V., Prabhudesai, S., Zhou, Y., Zon, L., McCann, K.L., Baserga, S. and Yelick, P.C. (2014) Tissue specific roles for the ribosome biogenesis factor Wdr43 in zebrafish development. PLoS Genet 10, e1004074 CrossRef PubMed.
51. p53 stabilization. Blood 118, 5458-5465 CrossRef PubMed.
52. p53 activation contributing to hematopoietic defects through RNA processing. PLoS One 7, e30188 CrossRef PubMed.
53. Gu, B.-W., Bessler, M. and Mason, P.J. (2008) A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc. Natl. Acad. Sci. 105, 10173-10178 CrossRef.
54. p53-mediated dark skin and pleiotropic effects. Nat. Genet. 40, 963-970 CrossRef PubMed.
55. p53 protein family. Blood 112, 5228-5237 CrossRef PubMed.
56. p53-mediated biliary defects caused by knockdown of cirh1a, the zebrafish homolog of the gene responsible for North American Indian childhood cirrhosis. PLoS One 8, e77670 CrossRef PubMed.
57. p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome. Nat. Med. 16, 59-66 CrossRef PubMed.
58. p53 mutations in cancer. Nat. Cell. Biol. 15, 2-8 CrossRef PubMed.
59. Shwachman, H., Diamond, L.K., Oski, F.A. and Khaw, K.T. (1964) The syndrome of pancreatic insufficiency and bone marrow dysfunction. J. Pediatr. 65, 645-663 CrossRef PubMed.
60. Bodian, M., Sheldon, W. and Lightwood, R. (1964) Congenital hypoplasia of the exocrine pancreas. Acta Paediatr. 53, 282-293 CrossRef PubMed.
61. Aggett, P.J., Cavanagh, N.P., Matthew, D.J., Pincott, J.R., Sutcliffe, J. and Harries, J.T. (1980) Shwachman's syndrome. A review of 21 cases. Arch. Dis. Child. 55, 331-347 CrossRef PubMed.
62. Finch, A.J., Hilcenko, C., Basse, N., Drynan, L.F., Goyenechea, B., Menne, T.F., Gonzalez Fernandez, A., Simpson, P., D'Santos, C.S., Arends, M.J. et al. (2011) Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev 25, 917-929 CrossRef PubMed.
63. Gijsbers, A., Garcia-Marquez, A., Luviano, A. and Sanchez-Puig, N. (2013) Guanine nucleotide exchange in the ribosomal GTPase EFL1 is modulated by the protein mutated in the Shwachman-Diamond syndrome. Biochem. Biophys. Res. Commun. 437, 349-354 CrossRef PubMed.
64. Asano, N., Atsuumi, H., Nakamura, A., Tanaka, Y., Tanaka, I. and Yao, M. (2014) Direct interaction between EFL1 and SBDS is mediated by an intrinsically disordered insertion domain. Biochem. Biophys. Res. Commun. 443, 1251-1256 CrossRef PubMed.
65. Weis, F., Giudice, E., Churcher, M., Jin, L., Hilcenko, C., Wong, C.C., Traynor, D., Kay, R.R. and Warren, A.J. (2015) Mechanism of eIF6 release from the nascent 60S ribosomal subunit. Nat. Struct. Mol. Biol. 22, 914-919 PubMed.
66. Tourlakis, M.E., Zhang, S., Ball, H.L., Gandhi, R., Liu, H., Zhong, J., Yuan, J.S., Guidos, C.J., Durie, P.R. and Rommens, J.M. (2015) In vivo senescence in the Sbds-deficient murine pancreas: cell-type specific consequences of translation insufficiency. Plos Genet. 11, e1005288 CrossRef PubMed.
67. p53-independent role in zebrafish pancreas development. Development 139, 3232-41 CrossRef PubMed.
68. Wan, Y., Zhang, Q., Zhang, Z., Song, B., Wang, X., Zhang, Y., Jia, Q., Cheng, T., Zhu, X., Leung, A.Y. et al. (2016) Transcriptome analysis reveals a ribosome constituents disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia. BMC Med. Genomics 9, 13 CrossRef PubMed.
69. Pospisilova, D., Cmejlova, J., Hak, J., Adam, T. and Cmejla, R. (2007) Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 92, e66-e67 CrossRef PubMed.
70. Payne, E.M., Virgilio, M., Narla, A., Sun, H., Levine, M., Paw, B.H., Berliner, N., Look, A.T., Ebert, B.L. and Khanna-Gupta, A. (2012) L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 120, 2214-2224 CrossRef PubMed.
71. Jaako, P., Debnath, S., Olsson, K., Bryder, D., Flygare, J. and Karlsson, S. (2012) Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. Blood 120, 2225-2228 CrossRef PubMed.
72. p53-independent way. Br. J. Haematol. 167, 524-528 CrossRef PubMed.
73. Wolfson, R.L., Chantranupong, L., Saxton, R.A., Shen, K., Scaria, S.M., Cantor, J.R. and Sabatini, D.M. (2016) Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43-48 CrossRef PubMed.
74. Aspesi, A., Pavesi, E., Robotti, E., Crescitelli, R., Boria, I., Avondo, F., Moniz, H., Da Costa, L., Mohandas, N., Roncaglia, P. et al. (2014) Dissecting the transcriptional phenotype of ribosomal protein deficiency: implications for Diamond-Blackfan Anemia. Gene 545, 282-289 CrossRef PubMed.
75. Dinman, J.D. (2016) Pathways to specialized ribosomes: The Brussels lecture. J. Mol. Biol. 428, 2186-2194.
76. Xue, S. and Barna, M. (2012) Specialized ribosomes: A new frontier in gene regulation and organismal biology. Nat. Rev. Mol. Cell Biol. 13, 355-369 CrossRef PubMed.
77. Kondrashov, N., Pusic, A., Stumpf, C.R., Shimizu, K., Hsieh Andrew, C., Xue, S., Ishijima, J., Shiroishi, T. and Barna, M. (2005) Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 145, 383-397 CrossRef.
78. Deschamps, J. and van Nes, J. (2005) Developmental regulation of the Hox genes during axial morphogenesis in the mouse. Development 132, 2931-2942 CrossRef PubMed.
79. Lee, A.S., Burdeinick-Kerr, R. and Whelan, S.P. (2013) A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs. Proc. Natl. Acad. Sci. U.S.A. 110, 324-329 CrossRef PubMed.
80. Xue, S., Tian, S., Fujii, K., Kladwang, W., Das, R. and Barna, M. (2015) RNA regulons in Hox 5' UTRs confer ribosome specificity to gene regulation. Nature 517, 33-38 CrossRef PubMed.
81. Floor, S.N. and Doudna, J.A. (2016) Tunable protein synthesis by transcript isoforms in human cells. eLife 5, e10921 CrossRef PubMed.
82. Ingolia, N.T. (2014) Ribosome profiling: new views of translation, from single codons to genome scale. Nat. Rev. Genet. 15, 205-213 CrossRef PubMed.
83. Piekna-Przybylska, D., Decatur, W.A. and Fournier, M.J. (2008) The 3D rRNA modification maps database: with interactive tools for ribosome analysis. Nucleic Acids Res 36, D178-D183, (Database issue) CrossRef PubMed.
84. McMahon, M., Contreras, A. and Ruggero, D. (2015) Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease. Wiley Interdiscip. Rev. RNA 6, 173-189 CrossRef PubMed.
85. Sharma, S. and Lafontaine, D.L. (2015) 'View from a bridge': A new perspective on eukaryotic rRNA base modification. Trends Biochem. Sci. 40, 560-575 CrossRef PubMed.
86. Armistead, J., Khatkar, S., Meyer, B., Mark, B.L., Patel, N., Coghlan, G., Lamont, R.E., Liu, S., Wiechert, J., Cattini, P.A. et al. (2009) Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen-Conradi syndrome. Am. J. Hum. Genet. 84, 728-739 CrossRef PubMed.
87. Wu, Q., Niebuhr, E., Yang, H. and Hansen, L. (2005) Determination of the/'critical region/' for cat-like cry of Cri-du-chat syndrome and analysis of candidate genes by quantitative PCR. Eur. J. Hum. Genet. 13, 475-485 CrossRef PubMed.
88. Valleron, W., Laprevotte, E., Gautier, E.F., Quelen, C., Demur, C., Delabesse, E., Agirre, X., Prosper, F., Kiss, T. and Brousset, P. (2012) Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia 26, 2052-2060 CrossRef PubMed.
89. Martens-Uzunova, E.S., Jalava, S.E., Dits, N.F., van Leenders, G.J., Moller, S., Trapman, J., Bangma, C.H., Litman, T., Visakorpi, T. and Jenster, G. (2012) Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 31, 978-991 CrossRef PubMed.
90. Ronchetti, D., Todoerti, K., Tuana, G., Agnelli, L., Mosca, L., Lionetti, M., Fabris, S., Colapietro, P., Miozzo, M., Ferrarini, M. et al. (2012) The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. Blood Cancer J. 2, e96 CrossRef PubMed.
91. Jaffrey, S.R. (2014) An expanding universe of mRNA modifications. Nat. Struct. Mol. Biol. 21, 945-946 CrossRef PubMed.
92. Carlile, T.M., Rojas-Duran, M.F. and Gilbert, W.V. (2015) Pseudo-Seq: genome-wide detection of pseudouridine modifications in RNA. Methods Enzymol. 560, 219-245 CrossRef PubMed.
93. Karijolich, J. and Yu, Y.T. (2011) Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395-398 CrossRef PubMed.
94. p53-dependent checkpoint. J. Immunol. 194, 200-209 CrossRef PubMed.
95. p53-dependent checkpoint. Immunity 26, 759-772 CrossRef PubMed.
96. Bortoluzzi, S., d'Alessi, F., Romualdi, C. and Danieli, G.A. (2001) Differential expression of genes coding for ribosomal proteins in different human tissues. Bioinformatics 17, 1152-1157 CrossRef PubMed.
97. Thompson, M.K., Rojas-Duran, M.F., Gangaramani, P. and Gilbert, W.V. (2016) The ribosomal protein Asc1/RACK1 is required for efficient translation of short mRNAs. ELife 5, e11154.
98. Cao, X.X., Xu, J.D., Liu, X.L., Xu, J.W., Wang, W.J., Li, Q.Q., Chen, Q., Xu, Z.D. and Liu, X.P. (2010) RACK1: A superior independent predictor for poor clinical outcome in breast cancer. Int. J. Cancer 127, 1172-1179 CrossRef PubMed.
99. Shi, S., Deng, Y.Z., Zhao, J.S., Ji, X.D., Shi, J., Feng, Y.X., Li, G., Li, J.J., Zhu, D., Koeffler, H.P. et al. (2012) RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway. J. Biol. Chem. 287, 7845-7858 CrossRef PubMed.
100. Shen, F., Yan, C., Liu, M., Feng, Y. and Chen, Y. (2013) RACK1 promotes prostate cancer cell proliferation, invasion and metastasis. Mol. Med. Rep. 8, 999-1004 PubMed.
101. Zhong, X., Li, M., Nie, B., Wu, F., Zhang, L., Wang, E. and Han, Y. (2013) Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma. Ann. Surg. Oncol. 20, 1044-1052 CrossRef PubMed.
102. Ruan, Y., Sun, L., Hao, Y., Wang, L., Xu, J., Zhang, W., Xie, J., Guo, L., Zhou, L., Yun, X. et al. (2012) Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J. Clin. Invest. 122, 2554-2566 CrossRef PubMed.
103. Deng, L., Starostina, N.G., Liu, Z.J., Rose, J.P., Terns, R.M., Terns, M.P. and Wang, B.C. (2004) Structure determination of fibrillarin from the hyperthermophilic archaeon Pyrococcus furiosus. Biochem. Biophys. Res. Commun. 315, 726-732 CrossRef PubMed.
104. Tafforeau, L., Zorbas, C., Langhendries, J.L., Mullineux, S.T., Stamatopoulou, V., Mullier, R., Wacheul, L. and Lafontaine, D.L. (2013) The complexity of human ribosome biogenesis revealed by systematic nucleolar screening of pre-rRNA processing factors. Mol. Cell 51, 539-551 CrossRef PubMed.
105. Wild, T., Horvath, P., Wyler, E., Widmann, B., Badertscher, L., Zemp, I., Kozak, K., Csucs, G., Lund, E. and Kutay, U. (2010) A protein inventory of human ribosome biogenesis reveals an essential function of exportin 5 in 60S subunit export. Plos Biol 8, e1000522 CrossRef PubMed.
106. Badertscher, L., Wild, T., Montellese, C., Alexander, L.T., Bammert, L., Sarazova, M., Stebler, M., Csucs, G., Mayer, T.U., Zamboni, N. et al. (2015) Genome-wide RNAi screening identifies protein modules required for 40S subunit synthesis in human cells. Cell Rep 13, 2879-2891 CrossRef PubMed.
107. O'Donohue, M.F., Choesmel, V., Faubladier, M., Fichant, G. and Gleizes, P.E. (2010) Functional dichotomy of ribosomal proteins during the synthesis of mammalian 40S ribosomal subunits. J. Cell Biol. 190, 853-866 CrossRef PubMed.
108. Sloan, K.E., Mattijssen, S., Lebaron, S., Tollervey, D., Pruijn, G.J. and Watkins, N.J. (2013) Both endonucleolytic and exonucleolytic cleavage mediate ITS1 removal during human ribosomal RNA processing. J. Cell Biol. 200, 577-588 CrossRef PubMed.
109. Burwick, N., Shimamura, A. and Liu, J.M. (2011) Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q-syndrome. Semin. Hematol. 48, 136-143 CrossRef PubMed.
110. Narla, A. and Ebert, B.L. (2010) Ribosomopathies: human disorders of ribosome dysfunction. Blood 115, 3196-3205 CrossRef PubMed.
111. Liu, J.M. and Ellis, S.R. (2006) Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood 107, 4583-4588 CrossRef PubMed.